Celltrion Pharm Valuation
| 068760 Stock | KRW 59,800 1,300 2.13% |
At this time, the firm appears to be overvalued. Celltrion Pharm shows a prevailing Real Value of W50400.0 per share. The current price of the firm is W59800.0. Our model approximates the value of Celltrion Pharm from analyzing the firm fundamentals such as Current Valuation of 5.87 T, profit margin of 0.09 %, and Return On Equity of 0.0891 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Celltrion Pharm's price fluctuation is very steady at this time. Calculation of the real value of Celltrion Pharm is based on 3 months time horizon. Increasing Celltrion Pharm's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Celltrion Pharm is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Celltrion Stock. However, Celltrion Pharm's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 59800.0 | Real 50400.0 | Hype 59800.0 | Naive 63448.34 |
The real value of Celltrion Stock, also known as its intrinsic value, is the underlying worth of Celltrion Pharm Company, which is reflected in its stock price. It is based on Celltrion Pharm's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Celltrion Pharm's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Celltrion Pharm helps investors to forecast how Celltrion stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Celltrion Pharm more accurately as focusing exclusively on Celltrion Pharm's fundamentals will not take into account other important factors: Celltrion Pharm Total Value Analysis
Celltrion Pharm is presently forecasted to have takeover price of 5.87 T with market capitalization of 2.1 T, debt of 39.4 B, and cash on hands of 80.19 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Celltrion Pharm fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.87 T | 2.1 T | 39.4 B | 80.19 B |
Celltrion Pharm Investor Information
About 58.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Celltrion Pharm had 1:1 split on the 21st of September 2024. Celltrion Pharm is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Celltrion Pharm Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Celltrion Pharm has an asset utilization ratio of 62.51 percent. This suggests that the Company is making W0.63 for each dollar of assets. An increasing asset utilization means that Celltrion Pharm is more efficient with each dollar of assets it utilizes for everyday operations.Celltrion Pharm Ownership Allocation
Celltrion Pharm holds a total of 34.05 Million outstanding shares. Celltrion Pharm retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Celltrion Pharm Profitability Analysis
The company reported the revenue of 398.74 B. Net Income was 34.58 B with profit before overhead, payroll, taxes, and interest of 72.93 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Celltrion Pharm's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Celltrion Pharm and how it compares across the competition.
About Celltrion Pharm Valuation
The stock valuation mechanism determines Celltrion Pharm's current worth on a weekly basis. Our valuation model uses a comparative analysis of Celltrion Pharm. We calculate exposure to Celltrion Pharm's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Celltrion Pharm's related companies.Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju, South Korea. Celltrionph is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct Celltrion Pharm's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Celltrion Pharm's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Celltrion Pharm's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Celltrion Pharm's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Celltrion Pharm's revenue streams: Identify Celltrion Pharm's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Celltrion Pharm's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Celltrion Pharm's growth potential: Evaluate Celltrion Pharm's management, business model, and growth potential.
- Determine Celltrion Pharm's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Celltrion Pharm's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Celltrion Stock analysis
When running Celltrion Pharm's price analysis, check to measure Celltrion Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celltrion Pharm is operating at the current time. Most of Celltrion Pharm's value examination focuses on studying past and present price action to predict the probability of Celltrion Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celltrion Pharm's price. Additionally, you may evaluate how the addition of Celltrion Pharm to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |